tetano
Editor, Senior Moderator
BMC Infect Dis
. 2021 Apr 8;21(1):333.
doi: 10.1186/s12879-021-06013-x.
Clinical and CT features of mild-to-moderate COVID-19 cases after two sequential negative nucleic acid testing results: a retrospective analysis
Yan Rong[SUP] 1 [/SUP], Fei Wang[SUP] 2 [/SUP], Jinfei Tian[SUP] 3 [/SUP], Xinhua Liang[SUP] 4 [/SUP], Jing Wang[SUP] 5 [/SUP], Xiaoli Li[SUP] 1 [/SUP], Dandan Zhang[SUP] 1 [/SUP], Jing Liu[SUP] 6 [/SUP], Huadong Zeng[SUP] 1 [/SUP], Yang Zhou[SUP] 7 [/SUP], Yi Shi[SUP] 8 [/SUP]
Affiliations
Abstract
Background: The clinical and imaging features of patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections that progressed to coronavirus disease 2019 (COVID-19) have been explored in numerous studies. However, little is known about these features in patients who received negative respiratory nucleic acid test results after the infections resolved. In this study, we aim to describe these features in a group of Chinese patients.
Methods: This retrospective study includes 51 patients with mild-to-moderate COVID-19 (median age: 34.0 years and 47.1% male) between January 31 and February 28, 2020. Demographic, clinical, laboratory, and computed tomography (CT) imaging data were collected before and after two consecutive negative respiratory SARS-CoV-2 tests.
Results: Following a negative test result, the patients' clinical symptoms continued to recover, but abnormal imaging findings were observed in all moderate cases. Specifically, 77.4% of patients with moderate COVID-19 exhibited multi-lobar lung involvement and lesions were more frequently observed in the lower lobes. The most common CT imaging manifestations were ground-glass opacities (51.6%) and fibrous stripes (54.8%%). Twelve of the 31 patients with moderate COVID-19 underwent repeated chest CT scans after a negative SARS-CoV-2 test. Among them, the ground-glass opacities decreased by > 60% within 1 week in seven patients (58.3%), but by < 5% in four patients (13.8%).
Conclusions: Following a positive and subsequent negative SARS-CoV-2 tests, patients with COVID-19 continued to recover despite exhibiting persistent clinical symptoms and abnormal imaging findings.
Keywords: COVID-19; Computed tomography; Negative nucleic acid testing; SARS-CoV-2.
. 2021 Apr 8;21(1):333.
doi: 10.1186/s12879-021-06013-x.
Clinical and CT features of mild-to-moderate COVID-19 cases after two sequential negative nucleic acid testing results: a retrospective analysis
Yan Rong[SUP] 1 [/SUP], Fei Wang[SUP] 2 [/SUP], Jinfei Tian[SUP] 3 [/SUP], Xinhua Liang[SUP] 4 [/SUP], Jing Wang[SUP] 5 [/SUP], Xiaoli Li[SUP] 1 [/SUP], Dandan Zhang[SUP] 1 [/SUP], Jing Liu[SUP] 6 [/SUP], Huadong Zeng[SUP] 1 [/SUP], Yang Zhou[SUP] 7 [/SUP], Yi Shi[SUP] 8 [/SUP]
Affiliations
- PMID: 33832444
- DOI: 10.1186/s12879-021-06013-x
Abstract
Background: The clinical and imaging features of patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections that progressed to coronavirus disease 2019 (COVID-19) have been explored in numerous studies. However, little is known about these features in patients who received negative respiratory nucleic acid test results after the infections resolved. In this study, we aim to describe these features in a group of Chinese patients.
Methods: This retrospective study includes 51 patients with mild-to-moderate COVID-19 (median age: 34.0 years and 47.1% male) between January 31 and February 28, 2020. Demographic, clinical, laboratory, and computed tomography (CT) imaging data were collected before and after two consecutive negative respiratory SARS-CoV-2 tests.
Results: Following a negative test result, the patients' clinical symptoms continued to recover, but abnormal imaging findings were observed in all moderate cases. Specifically, 77.4% of patients with moderate COVID-19 exhibited multi-lobar lung involvement and lesions were more frequently observed in the lower lobes. The most common CT imaging manifestations were ground-glass opacities (51.6%) and fibrous stripes (54.8%%). Twelve of the 31 patients with moderate COVID-19 underwent repeated chest CT scans after a negative SARS-CoV-2 test. Among them, the ground-glass opacities decreased by > 60% within 1 week in seven patients (58.3%), but by < 5% in four patients (13.8%).
Conclusions: Following a positive and subsequent negative SARS-CoV-2 tests, patients with COVID-19 continued to recover despite exhibiting persistent clinical symptoms and abnormal imaging findings.
Keywords: COVID-19; Computed tomography; Negative nucleic acid testing; SARS-CoV-2.